Zymeworks Inc. (ZYME) has a negative trailing P/E of -25.0, meaning the company is currently unprofitable on a trailing twelve-month (TTM) basis. The forward P/E of 23.4 based on analyst estimates suggests a return to profitability is expected. Trailing earnings yield is -3.99%, forward earnings yield 4.28%.
Criteria proven by this page:
Overall SharesGrow Score: 57/100 with 4/7 criteria passed.
| Year | P/E (TTM) | PEG Ratio | P/B Ratio | P/S Ratio | Dividend Yield |
|---|---|---|---|---|---|
| 2016 | -7.6 | -0.10 | 28.44 | 23.26 | - |
| 2017 | -15.5 | 0.22 | 1.39 | 3.12 | - |
| 2018 | -11.7 | -0.07 | -2.93 | 8.03 | - |
| 2019 | -11.9 | -0.06 | 7.03 | 58.43 | - |
| 2020 | -13.2 | 2.02 | 5.81 | 61.13 | - |
| 2021 | -4.0 | -0.30 | 3.43 | 32.03 | - |
| 2022 | 4.1 | -0.03 | 1.04 | 1.24 | - |
| 2023 | -6.0 | 0.03 | 1.54 | 9.41 | - |
| 2024 | -9.1 | 1.56 | 3.28 | 14.55 | - |
| 2025 | -24.5 | 0.73 | 7.39 | 18.72 | - |
| Year | EPS (Diluted) | Revenue | Net Income | Net Margin |
|---|---|---|---|---|
| 2016 | $-1.72 | $11.01M | $-33.81M | -307.1% |
| 2017 | $-0.49 | $51.76M | $-10.41M | -20.1% |
| 2018 | $-1.26 | $53.02M | $-36.56M | -68.9% |
| 2019 | $-3.83 | $29.54M | $-145.44M | -492.3% |
| 2020 | $-3.58 | $38.95M | $-180.55M | -463.5% |
| 2021 | $-4.06 | $26.68M | $-211.84M | -794% |
| 2022 | $1.90 | $412.48M | $124.34M | 30.1% |
| 2023 | $-1.72 | $76.01M | $-118.67M | -156.1% |
| 2024 | $-1.62 | $76.3M | $-122.7M | -160.8% |
| 2025 | $-1.08 | $105.97M | $-81.13M | -76.6% |
| Year | EPS (Avg) | EPS Range | Revenue (Avg) | Revenue Range | Analysts |
|---|---|---|---|---|---|
| 2026 | $1.19 | $-1.47 – $5.98 | $294.64M | $99.23M – $532.43M | 9 |
| 2027 | $0.30 | $-0.39 – $1.29 | $204.91M | $142.53M – $308.91M | 7 |
| 2028 | $0.03 | $-0.26 – $0.34 | $184.18M | $183.87M – $184.48M | 6 |
| 2029 | $0.58 | $0.15 – $1.10 | $295.41M | $124.92M – $496.92M | 4 |
| 2030 | $0.92 | $0.23 – $1.74 | $392.13M | $165.82M – $659.62M | 2 |
